...
首页> 外文期刊>Japanese Journal of Pharmacology >STUDIES ON THE CLASSIFICATION OF THE ENZYMES HYDRO-LYZING ESTER-FORM DRUGS IN LIVER MICROSOMES
【24h】

STUDIES ON THE CLASSIFICATION OF THE ENZYMES HYDRO-LYZING ESTER-FORM DRUGS IN LIVER MICROSOMES

机译:肝微粒体中酶水解酯形式药物的分类研究

获取原文

摘要

References(35) Cited-By(3) The drug-metabolizing enzymes catalyzing such reactions as oxidation, reduction, conjugation and hydrolysis have been reported to be localized mainly in liver microsomes (1, 2). Microsomes may also be considered as hydrolytic particles (3). The enzymes hydrolyzing ester-form drugs, e.g. aspirin (4-6), procaine (7), cocaine (8-11), atropine (8, 12, 13) and choline-esters (14, 15) have also been shown to be in the liver and some other tissues, but little is known 'about the properties and intracellular localization of these esterases as compared with cholinesterase which is closely related to synaptic transmission. It appears of interest to investigate drug-metabolizing enzymes in liver microsomes further to elucidate their pharmacological actions and mechanisms of detoxication. As a fundamental classification of esterases, Aldridge (16) showed that 10-5 M organophosphorous compounds inhibit many enzymes possessing carboxylic esterase activity while other esterases are unaffected. He has named the latter A-type and the former B-type esterase. Neither A nor B-type are sensitive to 10-5 M eserine. Cholinesterase is inhibited completely both by 10-6 M organophosphates and by 10-5 M eserine. Subsequently A and B-types and cholinesterase in many vertebrate plasmata were separated electrophoretically by Goutier (17) and Augustinsson (18). Microsomal esterases have not been examined with this technique. The present paper describes experiments on the classification of esterases, especially drug-hydrolyzing enzymes, in liver microsomes of some rodents. The microsomes “solubilized” with sodium deoxycholate were fractionated chromatographically or electrophoretically, and the sensitivities of the esterases in each fraction to inhibitors and their kinetics were investigated.
机译:参考文献(35)Cited-By(3)据报道,催化诸如氧化,还原,结合和水解等反应的药物代谢酶主要位于肝脏微粒体中(1、2)。微粒体也可以被视为水解颗粒(3)。水解酯形式药物的酶,例如阿司匹林(4-6),普鲁卡因(7),可卡因(8-11),阿托品(8、12、13)和胆碱酯(14、15)也存在于肝脏和其他一些组织中,但是与与突触传递密切相关的胆碱酯酶相比,关于这些酯酶的性质和细胞内定位知之甚少。研究肝微粒体中的药物代谢酶以进一步阐明其药理作用和解毒机理似乎是令人感兴趣的。作为酯酶的基本分类,Aldridge(16)表明10-5 M有机磷化合物会抑制许多具有羧酸酯酶活性的酶,而其他酯酶则不受影响。他已将后者命名为A型酯酶,而将先前的B型酯酶命名为。 A型和B型都不对10-5 M色氨酸敏感。胆碱酯酶被10-6 M有机磷酸酯和10-5 M色氨酸完全抑制。随后,Goutier(17)和Augustinsson(18)通过电泳分离了许多脊椎动物血浆中的A和B型以及胆碱酯酶。微粒体酯酶尚未用该技术检查。本文描述了一些啮齿动物肝脏微粒体中酯酶特别是药物水解酶分类的实验。色谱或电泳分离用脱氧胆酸钠溶解的微粒体,并研究每个馏分中酯酶对抑制剂及其动力学的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号